Anubhav Plast and Avience Biomedicals Launch SME IPOs with Differing Market Interest
Anubhav Plast Ltd and Avience Biomedicals are launching SME IPOs this week. Anubhav Plast's Rs 24 crore IPO, priced at Rs 77-80 per share, opens June 19 and closes June 23 on the BSE SME platform, with no grey market premium indicating muted listing expectations. Avience Biomedicals' Rs 30.24 crore IPO, priced at Rs 196-208 per share, opens June 18 and closes June 22 on NSE SME, showing a strong grey market premium of Rs 36, suggesting anticipated listing gains. Both companies plan to use proceeds for expansion and operations.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 100%, Right 0%). Overall sentiment is neutral (65/100). Lens Score 34/100 — low public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- economictimes— balanced framing, neutral sentiment
- news18— balanced framing, neutral sentiment
- economictimes— balanced framing, positive sentiment
AI Analysis
The articles focus on financial and market details of the IPOs without political framing. Coverage centers on company performance, IPO specifics, and market indicators, reflecting a business and investment perspective. There is no evident political viewpoint or partisan framing, as the sources present factual information relevant to investors and market participants.
The overall tone is neutral to positive, emphasizing factual IPO details and market interest levels. Avience Biomedicals' strong grey market premium suggests investor optimism, while Anubhav Plast's nil premium indicates subdued expectations. The coverage balances these sentiments without exaggeration, providing an informative outlook on both offerings.
How 3 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.